Employees
Teresa Isele
Chief Executive Officer
Employed at Rhenman & Partners since: 2023
Teresa has worked in different roles within the financial industry since 2011 and has, among others, served as CEO for Swedsec and acting CEO for Första AP-fonden.
Education: Law degrees from Humboldt University Berlin, King’s College London and Stockholm University.
Henrik Rhenman
Founding Partner / Chief Investment Officer
Employed at Rhenman & Partners since: 2008
Over 25 years of experience in portfolio management.
Education: Biochemist, Royal Institute of Technology, B.Sc., Stockholm School of Economics.
Mikael Olsson
Chief Operating Officer
Employed at Rhenman & Partners since 2023.
20 years of experience in the financial and fund sector. Education: B.Sc. in Economics, Jönköping International Business School.
Kaspar Hållsten
Portfolio Manager
Employed at Rhenman & Partners since: 2017.
Education: Business Administration, Finance, B.Sc., Stockholm Business School.
Hugo Schmidt
Portfolio Manager
Employed at Rhenman & Partners since: 2020.
Education: B.Sc. Business & Economics, Stockholm School of Economics.
Amennai Beyeen
Portfolio Manager
Employed at Rhenman & Partners since: 2023.
15 years of experience in medical positions within the life science industry. Education: M.Sc. Biomedicine and a PhD, Karolinska Insitute.
Staffan Knafve
Senior Advisor
Affiliated to Rhenman & Partners since: 2012.
Over 30 years of experience in the stock market.
Education: LL.B., Master of Laws, University of Stockholm.
Erica von Bahr
Relationship Manager
Employed at Rhenman & Partners since: 2022.
10 years of experience in wealth management. Education: M.Sc. in Business Administration, Finance, Linköping University
Karin Hjertén
Communications Manager
Employed at Rhenman & Partners since: 2021.
15 years of experience from marketing and communications roles within the financial sector. Education: M.Sc. in Business and Economics, Karlstad University.
Camilla Hermansson
Assistant
Employed at Rhenman & Partners since: 2013.
Board of Directors
Professor Hans Wigzell
Chairman of the Board
Professor emeritus of Immunology, Karolinska Institutet.
Former president of Karolinska Institutet, head of the Infectious Disease Institute, the State Bacteriological Laboratory and chair of Karolinska Institutet’s Nobel Committee.
Member of the Royal Academy of Sciences and the Royal Swedish Academy of Sciences IVA.
Active board assignments: Sarepta Therapeutics, Raysearch Laboratories, Wigzellproduktion AB, Segulah Medical Acceleration.
Total number of active board assignments: 5.
Birgitta Stymne Göransson
Director
M.Sc. in Chemistry/Biotechnology, Royal Institute of Technology (KTH), and MBA Harvard Business School. Previously CEO of Memira Group, COO at Telefos, McKinsey Associate and Product manager at Gambro.
Board member RVRC Holding AB, Elekta AB, Pandora A/S, Bure Equity AB and Chairman of the Boards of Industrifonden.
Total number of active board assignments: 6
Lars Wedenborn
Director
Degree of Master of Science in Business and Economics, Uppsala Universitet
Chairman of the bord in AMF Tjänstepension
Board member in IPCO AB, The Stockholm Chamber of Commerce (Vice Chairman), Rederi AB Gotland and Tebede AB
Previously CEO of FAM AB, CFO Alfred Berg and CFO Investor AB
Previously Board member at Nasdaq Group Inc, SKF, Grand Hôtel, FAM, Nyvik Group and Höganäs AB
Total number of active board assignments: 6
Dan Hoflund
Director
Lawyer (jurist), LL.M in Law, Uppsala University Previously:
Associate Judge (hovrättsassessor) Svea Court of Appeal, Legal Counsel Skandia Insurance Company, Deputy General Counsel and deputy head of the Legal & Security Deparment of Sweden Post, General Counsel Postgirot Bank AB, Group General Counsel Carnegie Investment Bank, Lawyer (Advokat)
Active board assignments: The Hans Wigzell Research Foundation, Hoflund Juridik AB
Total number of active board assignments: 3.
Henrik Rhenman
Director
Biochemist, Royal Institute of Technology and M.Sc., School of Business.
Founder and Managing Director, Rhenman & Partners. Former Founder & CIO, Carnegie Healthcare Funds, Carnegie Investment Bank. Managing Director, Portfolio Manager, SG Cowen, Boston. Portfolio manager, SEB Pharmaceutical Fund. Head of Analysis, Hagströmer & Qviberg.
Total number of active board assignments: 2.